Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1 (opens ClinicalTrials.gov)
- Sponsor
- Ospedale San Raffaele
- Enrolment
- 10
- Started
- 2024-01-01
- Last update
- 2024-02-22
Conditions: Wolfram Syndrome
Interventions: Tirzepatide
Research discovery
— registered studies
Verify this search on the official site ↗ · fetched Nov 5, 2026, 11:05 AM UTC
Status on this page
A registered trial is a plan, not a result. “Results posted” means the sponsor uploaded summary results to the registry; it says nothing about whether the treatment worked.
Conditions: Wolfram Syndrome
Interventions: Tirzepatide
Conditions: Obesity
Interventions: Tirzepatide, Placebo
Conditions: Healthy
Interventions: Tirzepatide, Placebo
Conditions: Obesity, Overweight, Metabolism and Nutrition Disorder
Interventions: Tirzepatide, Placebo
Conditions: Healthy, Type 2 Diabetes Mellitus (T2DM)
Interventions: Tirzepatide, Placebo, Dulaglutide
Conditions: Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes, Liver Fat
Interventions: GIP/GLP-1a
Conditions: Overweight, Obesity, Diabetes Mellitus, Type 2
Interventions: Tirzepatide, Acetaminophen
Conditions: Type 2 Diabetes
Interventions: Tirzepatide, Insulin Lispro (U100)
Conditions: Diabetes
Interventions: Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
Conditions: Overweight, Obesity
Interventions: LY3457263, Tirzepatide, Placebo
Conditions: Diabetes Mellitus, Type 2
Interventions: Tirzepatide, Placebo
Conditions: Healthy
Interventions: Tirzepatide
Conditions: Healthy
Interventions: Tirzepatide, Prefilled syringe (PFS), Auto-injector (AI)
Conditions: Healthy
Interventions: Tirzepatide, EE/NGM
Conditions: Healthy
Interventions: 14C Tirzepatide
Conditions: Hepatic Insufficiency
Interventions: Tirzepatide
Conditions: Renal Insufficiency, End Stage Renal Disease
Interventions: Tirzepatide
Conditions: Type 2 Diabetes Mellitus
Interventions: Tirzepatide, Placebo
Conditions: Diabetes Mellitus, Type 2
Interventions: Tirzepatide, Semaglutide, Placebo
Conditions: Type 2 Diabetes
Interventions: Tirzepatide, Insulin Glargine